As honorary CoChair of PanCAN Charlotte 2018, I am proud to support funding of important sarcopenia/pall care research #PurpleStride pancan.org/news/grantees-…

Important collaborative work from MDACC showing a feasible digital/tele method of teaching and increasing access to #PallOnc in Africa #ASC018

Excellent discussion by Andrew Aguirre, MD, PhD at #ASCO18 re biological heterogeneity in #pancsm and potential therapeutic implications.

Important discussion by Dr Ed Kim of #levinecancerinstitute re implementing precision medicine trials in the real world setting #ASC018

What drives end of life care variation? Shockingly, patient factors have no impact! Clinicians' biases, beliefs, and knowledge are steamrolling what patients want, and determining outcomes. It's the antithesis of personalized care; much work to do... #ASCO18 #pallonc #hpm

Congrats to fellow Dr Jagosky of #levinecancerinstitute for ASCO Merit Award re molecular sidedness of #coloncancer in #AYACSM

Great session and presentations @ASCO18 with great GI team. Proud to be part of this #levinecancerinstitute @Carolinas @atriumhealth

Hopefully this investigator initiated trial from #LevineCancerInstitute will show promise in refractory appendiceal cancer ASCO #GI19

That’s a wrap with this fabulous Levine Cancer group from tonight’s #stateofscience on GI Cancers! And also, Jordan Berlin, MD, of Vanderbilt University!

A concise and balanced discussion re SSAs and PRRT for #NeuroendocrineCancer. Hopefully will be able to optimize sequencing and reduce toxicities with ongoing trials such as the Phase II sunitinib vs PRRT in PNETs and the Phase III everolimus vs PRRT in GEP-NETs. @NETCancerBlog